<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03392259</url>
  </required_header>
  <id_info>
    <org_study_id>B-1712-438-307</org_study_id>
    <nct_id>NCT03392259</nct_id>
  </id_info>
  <brief_title>Usefulness of Cardiovascular Disease (CVD) Management Solution</brief_title>
  <official_title>Prospective Validation of Usefulness in Cardiovascular Disease (CVD) Management With CVD Management Solution Based on Interconnection to Hospital Examination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We previously developed the smartphone app (Heart4U) which is coupled with electronic medical
      record system in Seoul National University Bundang Hospital. In this study, we aim to
      evaluate clinical usefulness of smartphone app regarding the control of conventional risk
      factors in patients with history of cardiovascular disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of 10-year ASCVD risk (10-year ASCVD risk at 6 months - 10-year ASCVD risk at baseline)</measure>
    <time_frame>6 months</time_frame>
    <description>delta 10-year ASCVD risk between baseline and 6months, %</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>3 &amp; 6 months</time_frame>
    <description>automated blood pressure, mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>3 &amp; 6 months</time_frame>
    <description>automated blood pressure, mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipid profiles (total cholesterol, LDL, HDL)</measure>
    <time_frame>6 months</time_frame>
    <description>lipid profiles at 6 months, mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body mass index</measure>
    <time_frame>6 months</time_frame>
    <description>body mass index at 6 months, kg/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>smoking rate</measure>
    <time_frame>6 months</time_frame>
    <description>smoking rate at 6 months, %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degree of moderate physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>Godin Leisure-Time Exercise Questionnaire, total score (0-7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>depression scale questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Patient Health Questionanaire-9, total score 27 (0-27)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug compliance</measure>
    <time_frame>6 months</time_frame>
    <description>Medication Adherence Rating Scale (MARS), total score 10 (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>App service satisfaction survey</measure>
    <time_frame>6 months</time_frame>
    <description>Patient Activation Measure-13, total score 39 (0-39)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">666</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conventional treatment + use of smartphone app.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smartphone app</intervention_name>
    <description>Installment and use of smartphone app</description>
    <arm_group_label>App group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with atherosclerotic cardiovascular diseae

               1. history of cardiovascular disease (acute myocardial infarction, unstable angina,
                  stable angina)

               2. history of revascularization including percutaneous coronary intervention,
                  peripheral angioplasty or bypass surgery

               3. history of stroke

               4. history of peripheral arterial disease presumed to be of atherosclerotic origin

          -  Patients who have smartphone and can use app by themselves

          -  Patients who can speak and read Korean language

        Exclusion Criteria:

          -  Patients with evidences of delirium, confusion or impaired consciousness

          -  Patients who are not familiar to smartphone or app

          -  Patients who are not supposed to follow the study protocol adequately.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Won Suh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Si-Hyuck Kang</last_name>
    <phone>82317877027</phone>
    <email>eandp303@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung-Won Suh</last_name>
      <phone>82-31-787-7016</phone>
      <email>suhjw1@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <zip>463707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ji-Hyun Lee</last_name>
      <phone>82-31-787-8805</phone>
      <email>94306@snubh.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2018</study_first_submitted>
  <study_first_submitted_qc>January 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2018</study_first_posted>
  <last_update_submitted>March 23, 2018</last_update_submitted>
  <last_update_submitted_qc>March 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jung-Won Suh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

